Crohn's Disease

Clinical Trials

Below is a list of Crohn's Disease clinical trials from the clinical trials database at Mayo Clinic.

Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

A Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to TNF Therapy
This study will compare the benefits and risks of ustekinumab to placebo. Placebo looks like the drug being studied but has no active ingredients. The purpose of this study is to determine whether or not treatment with ustekinumab improves symptoms of Crohn?s disease and also to look for any possible side effects in patients with this disease.
Read more

A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease
This randomized, placebo-controlled, parallel, multi-center, double-blind pilot study is designed to determine the effects of BLI-1300 ointment on perianal pain associated with active Perianal Crohn's Disease (PCD).
Read more

GSK1605786A in the Treatment of Subjects with Moderately-to-Severely Active Crohn's Disease
The main purpose of this study is to test the safety of the study drug GSK 1605786A and to see how well it works in people with active Crohn's disease. This study will look at how people react to and how the body uses the study drug, GSK1605786A, at different doses for the treatment of Crohn's disease.
Read more

Nurture Study - Pediatric Crohn's Disease
To find out if the drug called certolizumab pegol is effective and safe to use in children with Crohn's disease. Certolizumab pegol is a new medication that has been approved for treatment of adults with Crohn's disease in the United States and Switzerland.
Read more

The use of REMICADE® (infliximab) vs. placebo in preventing relapse of Crohn?s disease after surgical resection.
The purpose of this study is to assess the effects of REMICADE® (infliximab) in preventing relapse of Crohn?s disease after surgical resection. REMICADE® (infliximab) is a drug used to treat active Crohn?s disease and is being tested in an experiment to see if it may be useful in preventing relapse of Crohn's disease after surgical resection.
Read more